相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple negative breast cancer risk
Wen-Shin Chang et al.
BIOMEDICINE-TAIWAN (2016)
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling
Lara Rossi et al.
EXPERIMENTAL HEMATOLOGY (2015)
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals
Xianfan Ding et al.
MOLECULAR CANCER (2015)
Targeting a cell state common to triple-negative breast cancers
Markus K. Muellner et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2′-deoxycytidine
Zoe L. Vincent et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2015)
TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma
Tao Song et al.
ONCOTARGET (2015)
Biomarkers in triple negative breast cancer: A review
Budhi S. Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)
Triple-Negative Breast Carcinoma Current and Emerging Concepts
Robert Schmadeka et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2
Guangcun Cheng et al.
CANCER RESEARCH (2014)
Cytokine functions of TIMP-1
Christian Ries
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Triple-negative breast cancer: future prospects in diagnosis and management
Shereef Elsamany et al.
MEDICAL ONCOLOGY (2014)
Patients with triple negative breast cancer: Is there an optimal adjuvant treatment?
Harold J. Burstein
BREAST (2013)
Elevated Plasma Tissue Inhibitor of Metalloproteinase-1 Levels Predict Decreased Survival in Castration-Resistant Prostate Cancer Patients
William K. Oh et al.
CANCER (2011)
Plasma Markers for Identifying Patients with Metastatic Melanoma
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2011)
Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression
Yang Lu et al.
MOLECULES AND CELLS (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
Ana Bosch et al.
CANCER TREATMENT REVIEWS (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept
Sabine C. Linn et al.
EUROPEAN JOURNAL OF CANCER (2009)
TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival
Elise Lambert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
Charlotte Aaberg-Jessen et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Tissue Inhibitor of Metalloproteinase 1 Expression Associated with Gene Demethylation Confers Anoikis Resistance in Early Phases of Melanocyte Malignant Transformation
Tatiana I. Ricca et al.
TRANSLATIONAL ONCOLOGY (2009)
Progress in matrix metalloproteinase research
Gillian Murphy et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein
Ki-Kyung Jung et al.
EMBO JOURNAL (2006)
TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27KIP1 protein
M. E. Taube et al.
ONCOGENE (2006)
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent
V Gouyer et al.
CANCER (2005)
Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase
JF Porter et al.
BRITISH JOURNAL OF CANCER (2004)
Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells
E Vorotnikova et al.
RADIATION RESEARCH (2004)
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers
S Curran et al.
CLINICAL CANCER RESEARCH (2004)
Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation
M Chromek et al.
INFECTION AND IMMUNITY (2004)
Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway
XW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
